Biote Recognized as 50-Fastest-Growing Women-Owned/Led Companies of 2021

Fastest Growing Women-Owned Companies of 2021

IRVING, Texas–(BUSINESS WIRE)–Biote has been announced as one of the 50 Fastest-Growing Women-Owned/Led Companies in the 14th annual ranking compiled by The Women Presidents’ Organization (WPO) in collaboration with JP Morgan Chase Commercial Banking. The companies on this year’s 50 Fastest list span a range of industries from consumer products to STEM, with eight companies in the healthcare field. From January to December of 2020, the 50 Fastest generated a combined $4.1 billion in revenue and collectively employed more than 24,000 people.

“This year’s honorees exemplify the commitment, determination and ingenuity that is necessary to thrive in today’s environment”Tweet this

“The Biote team and I are honored to be recognized by the Women Presidents’ Organization and feel renewed determination to provide people, and especially women, with a wider variety of options to stay healthy and well,” stated Terry S. Weber, CEO of Biote. “Our mission to convince the industry and scientific community to focus on underrepresented research and treatment options has resonated with people around the world. We are committed to answering this need by expanding access to life-enhancing health therapies that can truly impact patient lives.”

The 50-Fastest-Growing Women-Owned/Led companies were ranked according to a sales growth formula, combining percentage and absolute growth. To qualify for the ranking, businesses are required to be privately held, woman-owned or -led, and have reached annual revenues of at least $500,000 as of 2015 and every subsequent year.

Dr. Gary Donovitz, founder of Biote, has long been committed to raising the bar for health care and advancing responsible access to scientifically-based, life-enhancing health therapies. “Under Terry’s leadership, Biote is accelerating and scaling its work as a collaborative clinical educator and patient advocate in an underserved market,” stated Donovitz. “As we continue our efforts to advance clinical research and educate providers on the benefits of hormone optimization, we are also seeing patients becoming more proactive and empowered, and actively inquiring about how they can achieve a healthier and more satisfied life.”

“This year’s honorees exemplify the commitment, determination and ingenuity that is necessary to thrive in today’s environment,” said Thelma Ferguson, Managing Director & Northeast Segment Head at JPMorgan Chase Commercial Banking. “These exceptional women are living proof that necessity is the mother of innovation. Today, we are proud to support 50 extraordinary leaders who are redefining their industries and driving global economic growth.”

About Biote

Biote is a hormone optimization company that has translated over 80 years of scientific insight into clinically-validated medical approaches that identify and treat imbalances in the production of hormones. By partnering with over 4,700 medical providers across the United States, Biote is educating practitioners on the scientific evidence of the roles of hormones and supplements to support improved health, and on responsible treatment of patients. We are dedicated to helping patients live better, longer by changing the way healthcare is practiced on a global level.

About The Women Presidents’ Organization (WPO)

The WPO is the premier peer advisory organization connecting women who own multi-million-dollar companies. In monthly meetings across six continents, chapters of 20 women presidents from diverse industries invest time and energy in themselves and their businesses to drive their corporations to the next level. Local WPO chapters are coordinated by a professional facilitator and meet monthly to share business expertise and experience in a confidential setting. For more information, visit www.womenpresidentsorg.com.

About JPMorgan Chase Commercial Banking

JPMorgan Chase Commercial Banking is a business of JPMorgan Chase & Co. (NYSE: JPM), a leading global financial services firm with assets of $3.7 trillion and operations worldwide. Through its Middle Market Banking & Specialized Industries, Corporate Client Banking & Specialized Industries and Commercial Real Estate businesses, Commercial Banking serves emerging startups to midsize businesses and large corporations as well as government entities, not-for-profit organizations, and commercial real estate investors, developers and owners. Clients are supported through every stage of growth with specialized industry expertise and tailored financial solutions including credit and financing, treasury and payment services, international banking and more. Information about JPMorgan Chase Commercial Banking is available at www.jpmorganchase.com/commercial.

About This Site

When considering bioidentical hormone replacement therapy, or BHRT, you will find many BHRT options available. Here we look at multiple companies specializing in BHRT and break down each one to learn more about the company, their approach to bioidentical hormones replacement therapy, their treatment options, what makes them different, and the pros and cons of each one.

Bioidentical Hormone Replacement Therapy News

“FDA Warning Letter to EvexiPEL’s Pellet Supplier, Farmakeio

“FDA Warning Letter to EvexiPEL’s Pellet Supplier, Farmakeio

During the inspection, the FDA investigator noted that drug products produced by your facility failed to meet the conditions of section 503B. The evidence collected indicates that your facility’s drug products were not compounded in an outsourcing facility that is in compliance with the requirements of section 503B

read more
Hormone Replacement Therapy Market Analysis By Major Players Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG

Hormone Replacement Therapy Market Analysis By Major Players Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG

The Global Hormone Replacement Therapy Market, by Route of Administration (Parenteral and Oral), by Therapy Type (Testosterone Replacement Therapy, Thyroid Replacement Therapy, Estrogen Replacement Therapy, and HGH (Human Growth Hormone) Replacement Therapy), by Application (Menopause, Hypothyroidism, Growth Hormone Deficiency, and Male Hypogonadism), by Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies), and by Region (North America, Asia Pacific, Europe, Latin America, Middle East, and Africa) had a market valuation of US$ 10.58 Billion in 2017, and is estimated to grow at a CAGR of 5.2 percent during the forecast period (2018 – 2026).

read more
How Hypogonadism Is Treated

How Hypogonadism Is Treated

Hypogonadism, a condition in which the body produces insufficient sex hormones, causes a wide range of symptoms that vary based on age and sex at birth.

read more
BodyLogicMD Announces $5,000 Scholastic Scholarship for Medical Students Interested in Pursuing a Career Focused in Achieving Better Patient Care and Outcomes

BodyLogicMD Announces $5,000 Scholastic Scholarship for Medical Students Interested in Pursuing a Career Focused in Achieving Better Patient Care and Outcomes

BodyLogicMD, the most highly-trained network of practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, is offering a $5,000 scholarship per semester to one deserving medical student with aspirations of a career that is centered on optimal health and healing in the field of integrative medicine.

read more